Multiplex gastrointestinal pathogen panels: implications for infection control

Kenneth H Rand1, Elizabeth E Tremblay2, Mari Hoidal3

  • 1Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610.

Insights

Molecular testing for gastrointestinal (GI) infections in hospitalized patients identified other pathogens in 22.2% of cases, impacting isolation decisions. Multiplex GI panels can improve patient isolation protocols and reduce healthcare-associated infections.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Hospital Epidemiology

Background:

  • Diarrhea in acute care hospitals has diverse causes, both infectious and noninfectious.
  • Current Centers for Disease Control and Prevention (CDC) guidelines recommend contact precautions for infectious diarrhea, but reliable molecular diagnostics are needed to identify causative agents.
  • Accurate diagnosis is crucial for appropriate patient isolation and preventing the spread of infections within healthcare settings.

Purpose of the Study:

  • To evaluate the utility of the FilmArray GI Panel in identifying infectious agents in inpatient diarrheal stool specimens.
  • To assess the impact of molecular diagnostic results on patient isolation decisions and potential nosocomial transmission.
  • To determine the proportion of patients who were incorrectly isolated or could have been removed from isolation based on multiplex GI panel testing.

Main Methods:

  • Retrospective analysis of 158 inpatient diarrheal stool specimens previously tested negative for Clostridium difficile and/or rotavirus.
  • Use of the FilmArray GI Panel (BioFire Diagnostics) for multiplex detection of a wide range of gastrointestinal pathogens.
  • Review of patient isolation status and duration based on conventional testing versus FilmArray GI Panel results.

Main Results:

  • The FilmArray GI Panel detected at least one additional infectious agent in 22.2% of the tested specimens.
  • Of the patients with a positive GI panel result, 60% were never placed in appropriate isolation, contributing to 109 patient-days of potential transmission.
  • Conversely, 20.3% of patients with negative GI panel results could have been removed from isolation, optimizing resource utilization.

Conclusions:

  • Multiplex gastrointestinal panels significantly improve the identification of infectious diarrhea agents in hospitalized patients.
  • Utilizing these molecular assays can lead to more accurate patient isolation decisions, reducing both under-isolation and over-isolation.
  • Implementation of multiplex GI panels has the potential to decrease nosocomial transmission of infectious gastroenteritis agents.

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
50
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K